Merck & Co. Inc. closed 29.03% below its 52-week high of $134.63, which the company reached on June 25th.

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...

The NHL has some of the most historic and unique logos in the entire world of sports. With the Seattle Kraken now in the fold, we can rank 32 logos around the league. There are many great logos ...

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) yesterday and set a price target of $110.00. The company’s shares closed last Friday at $99.70.

British car brand Jaguar unveiled a new logo and wordmark as part of the company's shift away from making petrol-powered cars towards electric only. The new branding centres around an uppercase J ...

Merck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the U.S. Food and Drug Administration's website. Zinplava, first approved by ...

Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 models include a multi-functional Double Tap gesture that you might not know about or haven't yet got around to trying. Here's everything ...

(Reuters) - Merck said on Thursday its experimental drug combination to treat some adults with HIV-1 infection met the main goal of two late-stage studies.

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from the Phase 2 waveLINE-007 trial ...

RAHWAY, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the Phase 3 MOVe-NOW clinical trial to evaluate ...